Evidence map›Paper›PMID 39281710›Full record

ArticleJU open plus2024

Physician Perspectives on the Nonclinical Factors That Contribute to Decision-Making for Advanced Prostate Cancer Care: A Qualitative Study.

Deborah R Kaye, Karissa Tu, J Kelly Davis, Ada Campagna, Sharron L Docherty, Jeremy Kurnot, Tian Zhang, Daniel J George, Peter A Ubel

Abstract read
In one paragraph

Article in JU open plus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Deborah R KayeDepartment of Urology, Duke University, Durham, NC, USA.
Karissa TuSchool of Medicine, University of Washington, Seattle, WA, USA.
J Kelly DavisFuqua School of Business, Duke University, Durham, NC, USA.
Ada CampagnaFuqua School of Business, Duke University, Durham, NC, USA.
Sharron L DochertySchool of Nursing, Duke University, Durham, NC, USA.
Jeremy KurnotDepartment of Urology, Duke University, Durham, NC, USA.
Tian ZhangDivision of Medical Oncology, Department of Medicine, University of Texas Southwestern, Dallas, TX, USA.
Daniel J GeorgeDuke Cancer Institute, Duke University, Durham, NC, USA.
Peter A UbelDuke-Margolis Center for Public Policy, Duke University, Durham, NC, USA.

Funding

Improving outcomes of patients with advanced prostate cancer through a better understanding of provider decision-makingK08CA267062 · NCI · DUKE UNIVERSITY · PI Deborah R. Kaye · 2022 to 2026
$724k
NCI NIH HHS K08 CA267062
6 · The paper itself

Abstract

Introduction: Promising new treatments exist for advanced prostate cancer. Decision-making is complicated: there is minimal comparative effectiveness data; differing routes of administration, drug mechanisms-of-action and side effects; and significant price differences. These challenges contribute to variations in care and quality, treatment disparities, and lack of concordance with patient values. The aim of this study was to examine physician perspectives of factors influencing decision-making for first-line advanced prostate cancer treatments. Methods: We conducted a qualitative descriptive study of physicians who treat patients with advanced prostate cancer from 09/2021-06/2022. Participants were purposively sampled from across the United States. Results: Twenty-seven physicians participated. We identified seventeen domains and three overarching themes affecting physician decision-making for advanced prostate cancer care. The themes were: 1) physician and practice factors impact prescribing decisions, 2) health practice resource availability affects the likelihood patients will receive the recommended treatment, and that the treatment will be in-line with patients' values and 3) patient non-clinical factors influence physician decision-making, but patient values could be better incorporated into prescribing decisions. Based upon the analyses, we constructed a preliminary framework of clinician decision-making for advanced prostate cancer. Conclusions: Physicians perceive non-clinical patient, physician, and practice factors impact decision-making. These factors, therefore, must be considered when implementing programs to optimize a physician's ability to provide quality cancer care, reduce health care disparities and patient financial burden and provide patient goal-concordant care. The preliminary theoretical model of clinician decision-making for advanced prostate cancer care may also be used to inform these efforts.

Identifiers

PMID39281710
PMCPMC11392059

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.